Results 11 to 20 of about 203,879 (305)

Bivalirudin Attenuates Thrombin-Induced Endothelial Hyperpermeability via S1P/S1PR2 Category: Original Articles

open access: yesFrontiers in Pharmacology, 2021
Aims: To explore the role of the Sphingosine 1-Phosphate (S1P)/Receptor2 (S1PR2) pathway in thrombin-induced hyperpermeability (TIP) and to test whether bivalirudin can reverse TIP via the S1P-S1PRs pathway.Methods and Results: Using western blot, we ...
Haowen Ye   +9 more
doaj   +1 more source

Impact of hormone-associated resistance to activated protein C on the thrombotic potential of oral contraceptives: a prospective observational study. [PDF]

open access: yesPLoS ONE, 2014
The increased thrombotic risk of oral contraceptives (OC) has been attributed to various alterations of the hemostatic system, including acquired resistance to activated protein C (APC).
Heiko Rühl   +8 more
doaj   +1 more source

The role of thrombin in brain injury after hemorrhagic and ischemic stroke

open access: yesTranslational Stroke Research, 2020
Thrombin is increased in the brain after hemorrhagic and ischemic stroke primarily due to the prothrombin entry from blood either with a hemorrhage or following blood-brain barrier disruption. Increasing evidence indicates that thrombin and its receptors
Fenghui Ye   +4 more
semanticscholar   +1 more source

Thrombin induces a temporal biphasic vascular response through the differential phosphorylation of endothelial nitric oxide synthase via protease-activated receptor-1 and protein kinase C

open access: yesJournal of Pharmacological Sciences, 2022
Endothelial nitric oxide synthase (eNOS) is a critical regulatory enzyme that controls vascular tone via the production of nitric oxide. Although thrombin also modulates vascular tone predominantly via the activation of protease-activated receptors (PARs)
Akihiro Okamura   +13 more
doaj   +1 more source

Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting

open access: yesCardiovascular Diabetology, 2018
Background As a strong platelet agonist on the one hand and key molecule in plasmatic coagulation on the other hand, thrombin connects primary and secondary hemostasis.
Silvia Lee   +4 more
doaj   +1 more source

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function. [PDF]

open access: yesPLoS ONE, 2016
Thrombin is a highly plastic molecule whose activity and specificity are regulated by exosites 1 and 2, positively-charged domains that flank the active site. Exosite binding by substrates and cofactors regulates thrombin activity by localizing thrombin,
Calvin H Yeh   +4 more
doaj   +1 more source

Thrombin-induced platelet aggregation −effect of dabigatran using automated platelet aggregometry−

open access: yesPlatelets, 2020
Dabigatran, a direct oral thrombin inhibitor, has two therapeutic effects: anticoagulation; and antiplatelet activity. In the clinical field, evaluation of the effect of dabigatran on thrombin-induced platelet aggregation is difficult because of fibrin ...
Mie Shimizu   +10 more
doaj   +1 more source

The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1α by Thrombin

open access: yesImmunity, 2019
&NA; Ancient organisms have a combined coagulation and immune system, and although links between inflammation and hemostasis exist in mammals, they are indirect and slower to act. Here we investigated direct links between mammalian immune and coagulation
L. Burzynski   +11 more
semanticscholar   +1 more source

Complement and Coagulation System Crosstalk in Synaptic and Neural Conduction in the Central and Peripheral Nervous Systems

open access: yesBiomedicines, 2021
Complement and coagulation are both key systems that defend the body from harm. They share multiple features and are similarly activated. They each play individual roles in the systemic circulation in physiology and pathophysiology, with significant ...
Shani Berkowitz   +5 more
doaj   +1 more source

Factor Xa or thrombin: Is thrombin a better target? [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2007
The limitations of the vitamin K antagonists have prompted the development of new oral anticoagulants that target specific clotting enzymes. Most of the novel agents currently under development target either thrombin or factor Xa. As the final effector of blood coagulation and the most potent platelet agonist, thrombin is a logical target for new oral ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy